Clostridium difficile disease
Showing 26 - 50 of >10,000
Clostridium Difficile Colonization, Clostridium Difficile Diarrhea Trial in Hamilton (Vancomycin, Culturelle, Vancomycin
Not yet recruiting
- Clostridium Difficile Colonization
- Clostridium Difficile Diarrhea
- Vancomycin
- +3 more
-
Hamilton, Ontario, Canada
- +1 more
Aug 4, 2022
Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea Trial in Charlottesville
Recruiting
- Clostridioides Difficile Infection
- +3 more
-
Charlottesville, VirginiaUVA Health Systems
Nov 2, 2022
REMBRANDT: REcovery of MicroBiome fRom Antibiotics for Dental
Recruiting
- Dysbiosis
- +3 more
-
Philadelphia, PennsylvaniaThe Robert Schattner Center, University of Pennsylvania, School
Nov 16, 2022
Clostridium Difficile Trial in St. John's (Fecal Microbiota Transplantation, Vancomycin, Fecal Microbiota Transplantation
Withdrawn
- Clostridium Difficile
- Fecal Microbiota Transplantation
- +3 more
-
St. John's, Newfoundland and Labrador, CanadaHealth Sciences Centre
Apr 22, 2022
Clostridium Difficile Infections, Stem Cell Transplant Complications Trial (Vancomycin, Placebo)
Not yet recruiting
- Clostridium Difficile Infections
- Stem Cell Transplant Complications
- Vancomycin
- Placebo
- (no location specified)
Feb 17, 2022
Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell
- fecal microbiota transplantation (FMT)
- No fecal microbiota transplantation (FMT), routine management
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 25, 2022
Active C. Difficile Colitis Trial in Houston (Microbiota Transplantation (FMT))
Enrolling by invitation
- Active C. Difficile Colitis
- Microbiota Transplantation (FMT)
-
Houston, TexasMichael E DeBakey Veterans Affairs Medical Center
Feb 24, 2022
Immune Response to C.Difficile Infection
Recruiting
- Clostridium Difficile
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 31, 2022
Clostridium Difficile Trial in Chapel Hill (Stool specimen)
Completed
- Clostridium Difficile
- Stool specimen
-
Chapel Hill, North CarolinaUNC Chapel Hill
Mar 25, 2022
Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile
Completed
- Clostridium Infections
- C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
- +2 more
-
Gent, BelgiumGSK Investigational Site
Jun 9, 2022
Clostridioides Difficile Infection Trial in Leiden (biological, other, drug)
Not yet recruiting
- Clostridioides Difficile Infection
- 10E4 NTCD spores
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Jan 11, 2023
Clostridium Difficile Trial in Bronx (Bezlotoxumab)
Terminated
- Clostridium Difficile
-
Bronx, New YorkMontefiore Medical Center
Oct 13, 2022
Primary Clostridioides Difficile Infection (pCDI) Trial (Lyophilized fecal microbiome transfer, Vancomycin)
Not yet recruiting
- Primary Clostridioides Difficile Infection (pCDI)
- Lyophilized fecal microbiome transfer
- Vancomycin
- (no location specified)
Jan 24, 2023
Clostridium Difficile Trial in Miami, Chicago (Serum-derived bovine immunoglobulin/protein isolate (SBI), Placebo)
Terminated
- Clostridium Difficile
- Serum-derived bovine immunoglobulin/protein isolate (SBI)
- Placebo
-
Miami, Florida
- +2 more
Nov 10, 2021
Clostridium Difficile Infections in Hospitalized Patients on
Completed
- Clostridium Difficile
- no intervention
-
La Roche-sur-Yon, France
- +33 more
May 18, 2021
Clostridium Difficile Infection, Ulcerative Colitis, Indeterminate Colitis Trial in Stony Brook (Fecal Microbial
Completed
- Clostridium Difficile Infection
- +2 more
- Fecal Microbial Transplantation
-
Stony Brook, New YorkStony Brook University Hospital
Feb 21, 2022
REBYOTA™ Prospective Registry
Not yet recruiting
- Recurrence of Clostridium Difficile Infection
- (no location specified)
Apr 18, 2023
FQ Restriction for the Prevention of CDI
Enrolling by invitation
- Clostridium Difficile
- +2 more
- fluoroquinolone preprescription authorization
- Control
-
Phoenix, Arizona
- +7 more
Mar 2, 2022
Clostridium Difficile Infection Recurrence Trial in North Little Rock, Shreveport (RBX2660)
Recruiting
- Clostridium Difficile Infection Recurrence
-
North Little Rock, Arkansas
- +1 more
Apr 27, 2023
Clostridium Difficile Infection Trial in Minneapolis (Fecal Microbiota Therapy (FMT), Placebo)
Recruiting
- Clostridium Difficile Infection
- Fecal Microbiota Therapy (FMT)
- Placebo
-
Minneapolis, MinnesotaMinneapolis VA Health Care System, Minneapolis, MN
Mar 3, 2022
Clostridioides Difficile Infection Trial (LMN-201, Placebo)
Not yet recruiting
- Clostridioides Difficile Infection
- LMN-201
- Placebo
- (no location specified)
Nov 15, 2022
Clostridium Difficile Associated Disease Trial in United States (Clostridium difficile Vaccine, Placebo)
Completed
- Clostridium Difficile Associated Disease
- Clostridium difficile Vaccine
- Placebo
-
DeLand, Florida
- +16 more
Feb 11, 2021
Recipients Gut Microbiota After Fecal Microbiota Transplantation
Recruiting
- Clostridioides Difficile Infection Recurrence
- FMT from healthy donors
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 13, 2023
Clostridium Difficile Infection Recurrence Trial in Royal Oak (Bacillus velezensis DSM 33864, Placebo)
Not yet recruiting
- Clostridium Difficile Infection Recurrence
- Bacillus velezensis DSM 33864
- Placebo
-
Royal Oak, MichiganBeaumont Hospital
Dec 5, 2022
Clostridioides Difficile Infection Trial in Canada, United States (CRS3123, Active Comparator)
Recruiting
- Clostridioides Difficile Infection
- CRS3123
- Active Comparator
-
Fullerton, California
- +24 more
Jun 28, 2022